Fusion Genomics Corp.

Fusion Genomics Clinically Validating NGS Test for Infectious Disease; Eyes 2020 FDA Submission

GenomeWeb just published this article in their latest issue. It highlights our collaboration with Toronto’s Sunnybrook Research Institute to clinically validate our ONETest Rapid product that assays infectious diseases.

It goes on to feature our new Series A funding round. Any monies raised will go to support additional clinical studies to validate our syndromic ONETest products for sepsis and nosocomial acquired infections.

Unfortunately, it’s behind GenomeWeb’s paywall but we’re excited to alert you to this news! Press like this is great for us! Please share the link!